Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CSI Announces Operations Agreement With BioCare Corporation.


Business Editors

MILWAUKEE--(BUSINESS WIRE)--Aug. 14, 2000

CRITICARE SYSTEMS, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. (NASDAQ-NMS: CXIM) today announced an operations agreement with BioCare Corporation, a medical device manufacturer in Hsinchu, Taiwan. BioCare is a subsidiary of the Koo's Group, a Taiwan enterprise managing $26 billion dollars of assets. BioCare designs, manufactures and markets clinical research and medical diagnostic instruments and kits used in hospital laboratories and in cancer drug research worldwide.

CSI CSI Crime Scene Investigator
CSI CompuServe, Inc.
CSI Commodity Systems, Inc.
CSI Commodity Systems Inc. (Boca Raton, FL)
CSI Crime Scene Investigation (CBS TV show)
CSI Christian Schools International
 president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Emil Soika stated, "The agreement with BioCare provides CSI with outstanding technical, manufacturing and service resources to better address our growing international business. It also creates a logistical, cost effective, distribution point for the rapidly expanding Asian market."

Criticare Systems, Inc. (www.csiusa.com) designs, manufactures, and markets cost-effective patient monitoring systems and noninvasive non·in·va·sive
adj.
1. Not penetrating the body, as by incision. Used especially of a diagnostic procedure.

2. Not invading healthy tissue.
 sensors for a wide range of hospitals and alternate health care environments throughout the world.

This press release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
. Such statements refer to the Company's beliefs and expectations. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described. Such uncertainties include, but are not limited to, the timely completion of new products, regulatory approvals for new products, the risk of new and better technologies, risks relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 international markets, as well as general conditions and competition in the Company's markets. Other risks are set forth in CSI's reports and documents filed from time to time with the Securities and Exchange Commission.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1U3WI
Date:Aug 14, 2000
Words:239
Previous Article:A.B. Watley Group Receives $48 Million Private Equity Line Commitment Arranged by Investment Banking Firm Ladenburg Thalmann.
Next Article:J.D. Power and Associates Ranks Fidelity Investments Highest in Investor Satisfaction for Online Trading Services; Powerstreet Receives Top Honors...
Topics:



Related Articles
Steri-Oss Inc. Completes Merger With Nobel Biocare.
Criticare Systems, Inc. -CSI- Announces Agreement With Access Cardiosystems for Their New Automatic External Defibrillator.
Criticare Systems, Inc. - CSI - Expands Partnership With BioCare Corporation for China and Taiwan.
Criticare Systems, Inc. Quarterly Report.
Criticare Systems, Inc. Announces Agreement With Medex Corporation.
Criticare Systems, Inc. -CSI- Comment On Recent Share Price Volatility.
Nobel Biocare Prevails in Dental Implant Patent Dispute.
DiaSys Corporation Announces $1.46 Million Order In Latin America.
Plastic injection/rubber molding under one roof.
Women's health nurses think outside the square.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles